Why the study?
Hypertension-mediated organ damage frequently includes renal function decline involving several mechanisms, prompting a review of the state of the art on extracellular vesicles in hypertension and hypertension-related renal damage.
Extracellular vesicles hold promise as both biomarkers for hypertension-mediated kidney damage and as targeted drug delivery systems for renal diseases.
Extracellular vesicles may mediate hypertensive renal damage; leaves open their utility as biomarkers or targets pending clinical validation.
Hypertension-mediated organ damage frequently includes renal function decline in which several mechanisms are involved. The present review outlines the state of the art on extracellular vesicles in hypertension and hypertension-related renal damage. Emerging evidence indicates that extracellular vesicles, small vesicles secreted by most cell types and body fluids, are involved in cell-to-cell communication and are key players mediating biological processes such as inflammation, endothelial dysfunction or fibrosis, mechanisms present the onset and progression of hypertension-associated kidney disease. We address the potential use of extracellular vesicles as markers of hypertension-mediated kidney damage severity and their application as therapeutic agents in hypertension-associated renal damage. The capacity of exosomes to deliver a wide variety of cargos to the target cell efficiently makes them a potential drug delivery system for treatment of renal diseases.
No takes yet. Share an insight, caveat, or question.
Martínez-Arroyo et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: